KAPA
AMEX
$0.33
Kairos Pharma Ltd (KAPA)
Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. The company is headquartered in Los Angeles, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $8 (+2353.99%)
Market Cap
$6.75M
Free Cash Flow Yield
-55.76%
Beta (5Y)
0.62
Price Chart
Valuation
Market Cap$6.75M
P/B1.37
Profitability
Total Revenue (TTM)$157K
EBITDA-$5.84M
EPS-$0.29
Financial Health
Free Cash Flow Yield-55.76%
Growth & Risk
Beta (5Y)0.62
Sharpe Ratio-1.00